Related Experiment Video
Updated: Jul 3, 2026
09:22
Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model
Published on: April 2, 2017
Ischemic preconditioning in hepatic ischemia and reperfusion
Shohachi Suzuki1, Keisuke Inaba, Hiroyuki Konno
1Second Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan. shohachi88@msn.com
Current Opinion in Organ Transplantation
|August 8, 2008
Summary
Ischemic preconditioning protects the liver from prolonged injury by activating protective pathways. This strategy shows promise in liver transplantation, especially when combined with other treatments.
Area of Science:
- Hepatology
- Transplantation Immunology
- Cellular Signaling
Background:
- Hepatic ischemia and reperfusion injury is a major challenge in liver transplantation.
- Ischemic preconditioning (IP) offers a protective strategy against such injury.
Purpose of the Study:
- To review current insights into IP for hepatic ischemia and reperfusion injury.
- To explore experimental and clinical applications of IP in liver settings.
Main Methods:
- Review of experimental studies on IP mechanisms.
- Analysis of clinical data on IP in liver transplantation.
Main Results:
- Interleukin-6 signaling and STAT3 phosphorylation mediate IP protection.
- IP benefits are limited by donor age and ischemic duration (>60 min).
- Ascorbic acid or glucose may enhance IP by preserving mitochondrial function.
- Clinical IP in deceased donors reduces liver enzymes and primary nonfunction.
Conclusions:
- Understanding IP mechanisms is crucial for its therapeutic application in liver transplantation.
- IP represents a potential strategy to improve outcomes in liver transplantation.
